13.01.2016 • NewsDede WillamsBASFBP

BASF Targeted in EU’s Belgian Tax Repayment

German chemical giant BASF and UK oil and petrochemicals giant BP are among the estimate 35 multinational companies with extensive operations in Belgium being targeted by the EU’s competition commissioner, Margarethe Vestager, for receiving allegedly overgenerous tax benefits from the government of the Benelux country.

Vestager said her investigation revealed that Belgium’s so-called "express profit" tax scheme, which enabled multinational companies to pay lower taxes, was operating in breach of EU rules. She has ordered Belgium to rescind some of the benefits and collect a total of €700 million from the beneficiaries, including around €500 million from European players.

Initial reports said BASF, which operates a large back-integrated production hub at Antwerp, had been ordered to repay €200 million; however, the group later said the amount was exaggerated.

The Commissioner is said to be under pressure from the US government to go after European companies as she has American corporations such as Amazon, Apple, Starbucks and, most recently, McDonald’s.

In October 2015, the Commission began looking at tax benefits offered multinational companies by Luxembourg and the Netherlands. Ireland has also come under scrutiny.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.